"10.1371_journal.pone.0044899","none","2012-09-17T00:00:00Z","Yifan Xing; Ting Niu; Wenjuan Wang; Jinqing Li; Siying Li; Joseph S Janicki; Stacey Ruiz; Colin J Meyer; Xing Li Wang; Dongqi Tang; Yuxia Zhao; Taixing Cui","Shandong University Qilu Hospital Research Center for Cell Therapy, Key Laboratory of Cardiovascular Remodeling and Function Research, Jinan, China; Department of Traditional Medicine, Qilu Hospital of Shandong University, Jinan, China; Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina, United States of America; Department of Pharmacology, Reata Pharmaceuticals, Inc., Irving, Texas, United States of America","Conceived and designed the experiments: YX JL TC. Performed the experiments: YX TN WW JL SL. Analyzed the data: YX TN WW JL SL XLW DT TC. Contributed reagents/materials/analysis tools: SR CJM YZ TC. Wrote the paper: JSJ TC.","Stacey Ruiz and Colin J. Meyer are employed by Reata Pharmaceuticals, Inc. Reata Pharmaceuticals, Inc, synthesized, purified, and provided dihydro-CDDOtrifluoroethyl amide (dh404), which Reata Pharmaceuticals has a patent on. Reata Pharmaceuticals has numerous compounds in development from this same class of compounds. There are no marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","09","Yifan Xing","YX",12,TRUE,3,5,8,2,TRUE,TRUE,FALSE,0,NA,FALSE
